Cold-Eeze Deal Puts Homeopathic Brand At Center Of Mylan Consumer Business

The $50m deal adds a homeopathic brand to Mylan's portfolio that will lead its US consumer lineup; ProPhase will focus on dietary supplements; leave behind seasonal-demand products.